🟢 Heron Therapeutics is trading 7.1% up today in after-hours trading with no clear catalyst

Heron Therapeutics is trading 7.1% up at $0.51 in after-hours trading, extending its gains from the regular session despite a lack of fresh news or specific catalysts.

• The stock rose 11.2% during the regular session to close at $0.49, up from a prior close of $0.44.
• There are no new earnings reports, FDA updates, M&A activity, or analyst rating changes reported for the company today.
• The current price action appears to be a continuation of recent momentum rather than a reaction to a specific news-driven event.